0000897069-16-000764.txt : 20160315 0000897069-16-000764.hdr.sgml : 20160315 20160315142302 ACCESSION NUMBER: 0000897069-16-000764 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160315 DATE AS OF CHANGE: 20160315 EFFECTIVENESS DATE: 20160315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Romark Global Pharma, LLC CENTRAL INDEX KEY: 0001666694 IRS NUMBER: 660830393 STATE OF INCORPORATION: PR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-258025 FILM NUMBER: 161506474 BUSINESS ADDRESS: STREET 1: B5 TABONUCO STREET, SUITE #216, PMT 317 CITY: GUAYNABO STATE: PR ZIP: 00968 BUSINESS PHONE: (787) 919-7987 MAIL ADDRESS: STREET 1: B5 TABONUCO STREET, SUITE #216, PMT 317 CITY: GUAYNABO STATE: PR ZIP: 00968 FORMER COMPANY: FORMER CONFORMED NAME: Romark Laboratories, LLC DATE OF NAME CHANGE: 20160211 D/A 1 primary_doc.xml X0707 D/A LIVE 0001666694 Romark Global Pharma, LLC B5 TABONUCO STREET, SUITE #216, PMT 317 GUAYNABO PR PUERTO RICO 00968 (787) 919-7987 PUERTO RICO Romark Laboratories, LLC Limited Liability Company true 2014 Jean-Francois Rossignol, M.D., Ph.D. 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer Director Promoter Marc S. Ayers 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer Director Promoter Celine Rossignol 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer Brian Schnieders 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer W. Seymour Holt 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Director W. Andrew Krusen Jr. 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Director Pharmaceuticals Decline to Disclose 06b true 0000897069-16-000727 2015-10-09 false true true Convertible into Romark SCS Common Units false 100000 Francisco Jose Rivera 2303039 Pariter Securities, LLC 127836 243 Carretera #2 Guaynabo PR PUERTO RICO 00966 PR PUERTO RICO false 50000000 10710000 39290000 false 26 1500000 true 0 Commissions paid will be based on 3% of the gross proceeds raised in the offering through the services of the placement agent. 0 false Romark Global Pharma, LLC Brian Schnieders Brian Schnieders Chief Financial Officer 2016-03-15